Andrea Bafford, MD
Surgery · Baltimore, MDNPI 1710067442
Payments from drug & device makers
What this record shows
This record is dominated by education: $8,500 of the $11,672 with a category attached, or 72.8%. Intuitive Surgical accounts for 88.2% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $6,505 and has fallen 93.3% since, to $439 in 2025.
Across 38 payments — averaging $307.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- Johnson & Johnson$586
- AbbVie$160
- Davol Inc.$151
- Stryker$150
- Axonics, Inc.$123
- plus $206 from 5 others
What the payments were for
- Travel & lodging$8117%
- Food & beverage$2,33320%
- Education$8,50073%
- Gifts$280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 23 | $10,297 |
| Johnson & Johnson(2 entities) | 5 | $586 |
| AbbVie(2 entities) | 2 | $160 |
| Davol Inc. | 1 | $151 |
| Stryker | 1 | $150 |
| Axonics, Inc. | 1 | $123 |
| Pacira Pharmaceuticals Incorporated | 1 | $95 |
| Conmed Corporation | 1 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Dova Pharmaceuticals | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$7,612
- Da Vinci Surgical System$2,351
- STELARA$263
- Phasix Mesh$151
- 1788$150
- Enseal X1$144
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$125
- Axonics$123
How this compares
$11,672 in reported general payments places this provider in the 85th percentile of 493 surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 29 | $130 |
| Metronidazole | 29 | $43 |
Paid to pharmacies, not to this prescriber.
Other surgery in Baltimore
- Dorry SegevBaltimore$1.2M
- Thomas SwopeBaltimore$775K
- Alisa CokerBaltimore$702K
- John LedonneBaltimore$329K
- Martin MakaryBaltimore$135K
- Murtaza DawoodBaltimore$82K
- Christopher YouBaltimore$79K
- Daniel LubelskiBaltimore$67K
- Stephen YangBaltimore$45K
- Amelia PasleyBaltimore$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.